Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician via sales rep and described the occurrence of anaphylactic reaction in a 13-year-old female patient who received BEXSERO. Previously administered products included HPV vaccine (1st dose). Concurrent medical conditions included multiple allergies. Concomitant products included HPV vaccine. On an unknown date, the patient received BEXSERO. On an unknown date, 10 min after receiving BEXSERO, the patient experienced anaphylactic reaction (serious criteria GSK medically significant) and difficulty breathing. The patient was treated with EPIPEN. On an unknown date, the outcome of the anaphylactic reaction and difficulty breathing were recovered/resolved. The reporter considered the anaphylactic reaction and difficulty breathing to be probably related to BEXSERO. Additional details were received as follows: The reported concomitant dose of HPV vaccine was a subsequent dose of HPV vaccine. The patient did not experience an anaphylactic reaction with first dose of HPV vaccine. The patient was monitored for one hour at vaccination center and then sent home.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166